Purchase Order 36C24824P1065
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a $23,033 delivery order to Ailife Diagnostics, Inc. for genetic testing services at the Michael E. DeBakey VA Medical Center in Pearland, Texas. This firm-fixed-price delivery order, issued on June 13, 2025, represents the first ordering period under an indefinite delivery contract and is scheduled for completion by September 30, 2025. The award was not designated as a set-aside and was granted to the...
- This is a Delivery Order contract awarded by the Department of Veterans Affairs (VA) to Ailife Diagnostics, Inc., a woman-owned small business located in Pearland, Texas. The contract is for providing physician-ordered genetic testing services that are medically necessary for diagnosis, with a period of performance through September 30, 2026. The ceiling value of this Delivery Order is $224,300.00. Ailife Diagnostics has also been awarded an Indefinite Delivery Contract (IDC) with the Michael E....
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- CareDx Lab Solutions Inc., headquartered in West Chester, Pennsylvania, was awarded a delivery order valued at $23,972.68 by the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) on June 3, 2024. This firm fixed-price contract, which carries no set-aside designation, represents a delivery order issued against an existing single-award indefinite delivery contract valued at $787,000 with an ultimate completion date of June 2, 2027. The delivery order calls for the...
- The Department of Veterans Affairs (VA) awarded a firm fixed price delivery order contract to Personal Genome Diagnostics Inc., a for-profit small business, to provide oncology testing services. The $3,627,950.00 contract was set aside for small businesses and has a completion date of May 8, 2020. Personal Genome Diagnostics has received several small purchase orders from the VA in recent years to perform molecular tissue and DNA testing services, indicating the company supports the VA's genomic...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract, valued at $127,833.75, is for laboratory services related to Caredx's AlloSure kidney and heart tests, AlloMap heart tests, and other genetic blood testing services for transplant patients. The contract is a definitive contract with a firm fixed...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for transplant patients, was awarded a delivery order by Veterans Integrated Service Network (VISN) 16 on April 1, 2026, to provide laboratory testing services for post-transplant care. The firm fixed-price delivery order carries a ceiling value of $770,804.50 and extends through March 31, 2027. This award was not designated as a set-aside contract and will be performed in Houston, Texas. The contract...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
The Department of Veterans Affairs, specifically Veterans Integrated Service Network 8, awarded a $127.5K firm fixed-price purchase order to Ailife Diagnostics, Inc., a woman-owned small business based in Pearland, Texas, for kidney gene panel testing services at the Miami VA Medical Center. The contract, awarded on March 18, 2024, with an ultimate completion date of March 19, 2029, supports the diagnosis and management of chronic kidney disease for VA patients. This non-set-aside contract requires Ailife Diagnostics to process approximately 300 samples annually, deliver results within 21 days, and coordinate sample transportation and invoice processing through the VA's electronic systems. Ailife Diagnostics specializes in comprehensive genetic testing services for federal healthcare agencies and brings substantial experience to this engagement, having previously secured significant contracts with the VA and the Defense Health Agency. The company maintains an indefinite delivery contract valued at $1.12M with the Michael E. DeBakey VA Medical Center's Pathology & Laboratory Medicine Service running through September 2029, demonstrating established capability and performance history within the VA system. This kidney gene testing award represents a focused engagement supporting clinical operations at the Miami VA Medical Center and aligns with the company's core expertise in physician-ordered genetic testing panels across multiple medical specialties.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--FY24 - Fulgent CPRR Contract Base and 4 Option Years | 36C24824Q0282 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 | Solicitation 1/1 | 12/21/23, 1:32 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $50.0k | 3/5/26 | |
| P00003 | Other Administrative Action | ($147k) | 8/14/25 | |
| P00002 | Other Administrative Action | $75.0k | 3/6/25 | |
| Not listed | Not listed | $150.0k | 3/20/24 | |
| P00001 | Other Administrative Action | $0 | 3/20/24 |